Detalhe da pesquisa
1.
Asian participants' experience in phase 3/3b studies of long-acting cabotegravir and rilpivirine: Efficacy, safety, pharmacokinetic, and virological outcomes through week 96.
HIV Med
; 25(3): 381-390, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38147871
2.
Polymorphisms in the tumor necrosis factor-alpha gene promoter may predispose to severe silicosis in black South African miners.
Am J Respir Crit Care Med
; 165(5): 690-3, 2002 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11874815